このアイテムのアクセス数: 16
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s10654-025-01215-y.pdf | 907.26 kB | Adobe PDF | 見る/開く |
タイトル: | Two-step pragmatic subgroup discovery for heterogeneous treatment effects analyses: perspectives toward enhanced interpretability |
著者: | Komura, Toshiaki Bargagli-Stoffi, Falco J. Shiba, Koichiro Inoue, Kosuke ![]() ![]() |
キーワード: | Heterogeneous treatment effect Causal machine learning Scientific communication Diabetes Cardiovascular events |
発行日: | Feb-2025 |
出版者: | Springer Nature |
誌名: | European Journal of Epidemiology |
巻: | 40 |
号: | 2 |
開始ページ: | 141 |
終了ページ: | 150 |
抄録: | Effect heterogeneity analyses using causal machine learning algorithms have gained popularity in recent years. However, the interpretation of estimated individualized effects requires caution because insights from these data-driven approaches might be misaligned with the contextual needs of a human audience. Thus, a practical framework that integrates advanced machine learning methods and decision-making remains critically needed to achieve effective implementation and scientific communication. We introduce a 2-step framework to identify characteristics associated with substantial effect heterogeneity in a practically relevant format. The proposed framework applies distinct sets of covariates for (i) estimation of individualized effects and (ii) subgroup discovery and shows the subgroups with heterogeneity based on highly interpretable if-then rules. By referring to existing metrics of interpretability, we describe how each step contributes to leveraging a theoretical advantage of machine learning models while creating an interpretable and practically relevant framework. We applied the pragmatic subgroup discovery framework for the Look AHEAD (Action for Health in Diabetes) trial to assess practically relevant and comprehensive insights into the effect heterogeneities of intense lifestyle intervention for individuals with diabetes on cardiovascular mortality. Our analysis identified (i) individuals with history of cardiovascular disease and myocardial infarction had the least benefit from the intervention, while (ii) individuals with no history of cardiovascular diseases and HbA1c < 7% received the highest benefit. In summary, our practical framework for heterogeneous effects discovery could be a generic strategy to ensure both effective implementation and scientific communication when applying machine learning algorithms in epidemiological research. |
記述: | 効果の異質性を解釈するフレームワーク --機械学習を用いた解釈可能性のための実践的枠組みを提唱-- . 京都大学プレスリリース. 2025-03-10. |
著作権等: | © The Author(s) 2025 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. |
URI: | http://hdl.handle.net/2433/293633 |
DOI(出版社版): | 10.1007/s10654-025-01215-y |
PubMed ID: | 40038141 |
関連リンク: | https://www.kyoto-u.ac.jp/ja/research-news/2025-03-10-0 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス